Olumiant 4mg tablet contains an active component such as Baricitinib. It belongs to a class of drugs known as Janus kinase (JAK) inhibitors. It is primarily used to treat certain autoimmune conditions, particularly rheumatoid arthritis, a chronic autoimmune disorder that primarily affects the joints. This can enhance their quality of life and ability to perform daily activities. This can lead to a reduction in pain, swelling, and stiffness associated with rheumatoid arthritis. It is approved for use in cases where patients have not responded well to conventional disease-modifying antirheumatic drugs (DMARDs) or other treatments. It helps to reduce inflammation and manage the symptoms associated with rheumatoid arthritis. Additionally, during the COVID-19 pandemic, there was some interest in using this medication as a potential treatment for severe cases of COVID-19.

• Rheumatoid arthritis treatment
• Autoimmune condition management
• Combination therapy for rheumatoid arthritis
• Investigational use in COVID-19
• Immunosuppressive effects

Olumiant 4mg tablet is a Janus kinase (JAK) inhibitor, targeting JAK1 and JAK2 enzymes. These enzymes are integral to intracellular signaling pathways involved in immune responses and inflammation. By inhibiting JAK1 and JAK2, it interferes with transmitting signals that contribute to the activation of immune cells and the production of inflammatory molecules. This modulation of signaling pathways leads to a dampened immune response and reduced inflammation, effectively managing autoimmune conditions like rheumatoid arthritis.

Olumiant 4mg tablet is typically administered orally, which means it is taken by mouth as tablets. It is available as an oral tablet for easy ingestion. Your healthcare provider will determine the specific dosage and frequency of administration based on your medical condition and individual needs. 

• Serious infections
• Blood clots
• Malignancies
• Gastrointestinal perforations
• Liver abnormalities
• Upper respiratory tract infections
• Headache
• Increased liver enzymes
• High blood pressure
• Changes in blood cell counts
• Elevated cholesterol levels

Inform the doctor about your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Olumiant 4mg tablet, reducing effectiveness by causing undesirable side effects.

• Store at room temperature, between up to 20°C -25°C
• Keep away from moisture, heat, and light.
• It should not be frozen.
• Keep away from children and pets.

Discuss your cardiovascular health with your healthcare provider before starting Olumiant 4mg tablet. Monitor blood sugar levels closely and consult your healthcare provider if adjustments to diabetes management are needed. Gastrointestinal perforations, liver abnormalities, and possible gastrointestinal issues should be noted. Closely monitor liver enzymes, cholesterol, and blood pressure. Screen for hepatitis B before starting treatment. Vaccination schedules may need adjustment. Stomach and intestinal problems, surgery planning, cataracts, and drug allergies require attention. Use caution in individuals with a history of or risk factors for interstitial lung disease, as it may exacerbate this condition. Consider the risk of lymphoma and other malignancies might be increased with this medication. Protect your skin from sun exposure and report any skin changes to your healthcare provider. Regular eye check-ups are advisable.